Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness and safety of the suture-mediated closure system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. following endovascular peripheral arterial procedures.


Clinical Trial Description

Prospective, multi-center, randomized Comparative study using the Suture-mediated Closure System produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.as an investigational device and the Perclose® ProGlide Suture-Mediated Closure System as a comparator. After going through the confirmation of inclusion/exclusion criteria with signed subjects, they will have a procedure either of the two devices. The subjects should follow designated physician's instructions accurately during the clinical trial period. There are about 4 times evaluations Including screening. ;


Study Design


Related Conditions & MeSH terms

  • Percutaneous Intervention Via Femoral Artery

NCT number NCT05899478
Study type Interventional
Source Suzhou Hengruihongyuan Medical Technology Co. LTD
Contact
Status Not yet recruiting
Phase N/A
Start date June 2023
Completion date May 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT00590356 - Star-Close Versus Angio-Seal for Femoral Artery Hemostasis Phase 4
Recruiting NCT05334095 - Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease N/A